Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

NCT00294190 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer
Carcinoma, Small Cell

Interventions

DRUG: Topotecan

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]